<DOC>
	<DOCNO>NCT02908776</DOCNO>
	<brief_summary>MYDA-MI study randomize , placebo control , double blind study perform San Filippo Neri Hospital , Roma , Italy . The plan study duration 18 month . The objective assess effect pre-treatment probiotic Ecoviesel incidence magnitude peri-procedural myocardial damage cause coronary angioplasty stable patient . 250 patient chronic stable angina schedule coronary angiography possible ad hoc angioplasty randomize receive pre-treatment Ecoviesel sachet ( sachet contain 200 billion bacteria ) Placebo . The pre-treatment dosage 4 sachet probiotic Ecoviesel placebo least 2 week plan procedure . In patient undergo angioplasty treatment continue 4 week PCI secondary outcome measure perform end second stage .</brief_summary>
	<brief_title>MYocardial DAmage AND MIcrobiota STUDY</brief_title>
	<detailed_description />
	<mesh_term>Angina , Stable</mesh_term>
	<criteria>Patients chronic stable angina schedule coronary angiography possible ad hoc percutaneous coronary intervention Age &gt; 75 y.o Diabetes require treatment Abnormal cTnI level angiography Immunodeficiency status Need oral vitamin K antagonist Need antibiotic Use antibiotic probiotic within 4 week enrollment Cancer diseases affect 1 year prognosis Participation clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>